Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8153765 Anti-CD38 antibodies for the treatment of cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 16, 2007
Date of Patent
April 10, 2012
Patent Application Number
12441466
Patent Citations Received
‌
US Patent 12091466 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
3
‌
US Patent 12060432 Combination therapies with anti-CD38 antibodies
5
‌
US Patent 12065500 Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics
6
‌
US Patent 11708420 Subcutaneous formulations of anti-CD38 antibodies and their uses
7
‌
US Patent 11708419 Subcutaneous formulations of anti-CD38 antibodies and their uses
8
‌
US Patent 11713355 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
9
‌
US Patent 11939390 Methods of treating multiple myeloma
10
‌
US Patent 11964948 Bifunctional chelators and conjugates
11
‌
US Patent 11975081 Bifunctional chelators and conjugates
12
‌
US Patent 12012461 Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics
13
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8153765
Patent Primary Examiner
‌
Stephen Rawlings
Industry
Request Data

Find more entities like US Patent 8153765 Anti-CD38 antibodies for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo